61
Views
13
CrossRef citations to date
0
Altmetric
Editorial

Autism spectrum disorder-associated biomarkers for case evaluation and management by clinical geneticists

&
Pages 671-674 | Published online: 09 Jan 2014
 

Financial & competing interests disclosure

This research was supported by the nonprofit CoMeD, Inc. and by the nonprofit Institute of Chronic Illnesses, Inc. through a grant from the Brenen Hornstein Autism Research & Education (BHARE) Foundation. David Geier and Mark Geier have been involved in vaccine/biologic litigation and have a patent pending for the treatment of autism spectrum disorders. None of the authors has a financial interest in the Laboratory Corporation of America. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.